Regeneron Stock – Alexion Pharmaceuticals Inc. stock rises Wednesday, outperforms market
Shares of Alexion Pharmaceuticals Inc.
rose 1.01% to $155.29 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
rising 0.16% to 33,730.89 and the S&P 500 Index
falling 0.41% to 4,124.66. The stock’s rise snapped a two-day losing streak. Alexion Pharmaceuticals Inc. closed $7.31 below its 52-week high ($162.60), which the company reached on January 26th.
The stock outperformed some of its competitors Wednesday, as Gilead Sciences Inc.
rose 0.63% to $65.30, Vertex Pharmaceuticals Inc.
rose 0.55% to $217.13, and Regeneron Pharmaceuticals Inc.
rose 0.86% to $481.16. Trading volume (2.0 M) remained 383,119 below its 50-day average volume of 2.4 M.